Status:
UNKNOWN
Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass Surgery
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
The Ministry of Science, Technology and Innovation, Denmark
Conditions:
Obesity
Eligibility:
FEMALE
25-60 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate potential metabolic effects of resveratrol in morbidly obese women undergoing gastric bypass surgery. The investigators hypothesize that resveratrol will: ...
Eligibility Criteria
Inclusion
- Female
- 25-60 years
- Obesity (BMI \> 35 kg/m2)
- Have at least one element of the metabolic syndrome either hypertension and/or hypercholesterolemia (high triglyceride, low HDL-cholesterol)
- Undergoing gastric bypass surgery
- Written informed consent
Exclusion
- Any other relevant disease (e.g. diabetes, thyroid or parathyroid disease, heart, kidney or liver disease)
- May have arthrosis or depression
- Any present or previous malignancy
- History of smoking
- Alcohol dependency (more than 14 units of alcohol per week)
- Participation in studies with radioactive isotope within the last six months
- Hemoglobin under the normal range regarding to sex (under 7.3 mmol/l for women)
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01826279
Start Date
May 1 2013
End Date
August 1 2014
Last Update
January 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology and Internal Medicine
Aarhus C, Denmark, 8000